CandemirMKızıltunçEYamakBA.Association between the C-reactive protein-albumin-lymphocyte (CALLY) index and length of hospital stay in patients with heart failure. Angiology. Published online May 15, 2025. doi:10.1177/00033197251338416
2.
JiHLuoZYeL, et al. Prognostic significance of C-reactive protein-albumin-lymphocyte (CALLY) index after primary percutaneous coronary intervention in patients with ST-segment elevation myocardial infarction. Int Immunopharmacol. 2024;141:112860.
3.
LuoLLiMXiYHuJHuW.C-reactive protein-albumin-lymphocyte index as a feasible nutrition-immunity-inflammation marker of the outcome of all-cause and cardiovascular mortality in elderly. Clin Nutr ESPEN. 2024;63:346-353.
4.
HanDWuLZhouH, et al. Associations of the C-reactive protein-albumin-lymphocyte index with all-cause and cardiovascular mortality among individuals with cardiovascular disease: evidence from the NHANES 2001-2010. BMC Cardiovasc Disord. 2025;25(1):144.
5.
PanYWuTTDengCJ, et al. Association between the C-reactive protein-albumin-lymphocyte (CALLY) index and adverse clinical outcomes in CAD patients after PCI: findings of a real-world study. Rev Cardiovasc Med. 2024;25(4):111.
6.
IidaHTaniMKomedaK, et al. Superiority of CRP-albumin-lymphocyte index (CALLY index) as a non-invasive prognostic biomarker after hepatectomy for hepatocellular carcinoma. HPB (Oxford). 2022;24(1):101-115.
7.
KoenigWSagerHB.Inflammation and cardiovascular disease: new epidemiologic data and their potential implications for anti-cytokine therapy. Eur J Prev Cardiol. 2023;30(16):1728-1730.
8.
MillerVMRedfieldMMMcConnellJP.Use of BNP and CRP as biomarkers in assessing cardiovascular disease: diagnosis versus risk. Curr Vasc Pharmacol. 2007;5(1):15-25.
9.
GodalaMGaszyńskaEWalczakKMałecka-WojcieskoE.Evaluation of albumin, transferrin and transthyretin in inflammatory bowel disease patients as disease activity and nutritional status biomarkers. Nutrients. 2023;15(15):3479.
10.
SoaitaIYinWRubensteinDA.Glycated albumin modifies platelet adhesion and aggregation responses. Platelets. 2017;28(7):682-690.
11.
ManolisAAManolisTAMelitaHMikhailidisDPManolisAS.Low serum albumin: a neglected predictor in patients with cardiovascular disease. Eur J Intern Med. 2022;102:24-39.
12.
von HaehlingSDoehnerWAnkerSD. Nutrition, metabolism, and the complex pathophysiology of cachexia in chronic heart failure. Cardiovasc Res. 2007;73(2):298-309.
13.
CharachGGrosskopfIRothA, et al. Usefulness of total lymphocyte count as predictor of outcome in patients with chronic heart failure. Am J Cardiol. 2011;107(9):1353-1356.
